Study at a glance
What are free, albumin-bound and total vitamin D?
This page compares ways that 25-hydroxyvitamin D is carried in the blood. Most is attached to vitamin D-binding protein. A smaller amount is attached to another protein called albumin. A tiny amount is unattached, or free. A total measurement includes all three amounts.
Who was studied to compare free and total vitamin D?
The evidence includes tests on human blood and studies of people with liver disease. It also includes 472 people in a vitamin D supplement study. Two rare cases involved people who could not make the usual vitamin D-binding protein.
When did free and total vitamin D measurements differ?
In liver disease, total levels could be lower while the amount of free 25-hydroxyvitamin D remained relatively unchanged. Common inherited differences in the carrier protein affected total measurements more clearly than directly measured free amounts. The two rare cases had extremely low total levels without equally severe disruption of calcium control or bone health. These unusual cases do not show that ordinary low vitamin D levels are harmless.
Do these studies show that only free vitamin D matters?
The amount of carrier protein affects what a total blood measurement represents. Free vitamin D measurements do not tell us how vitamin D acts in every tissue. These studies do not establish that only free vitamin D matters. They also do not define a free vitamin D blood level that everyone should aim for.
Read the full article below ↓Circulating 25-hydroxyvitamin D exists mainly bound to vitamin D-binding protein, with a smaller albumin-bound pool and a tiny free fraction. These compartments are related by binding equilibrium, but they are not physiologically identical. This Study Summary gives the faster route through the evidence; the deeper methods, results and inference boundaries are in Free, Albumin-Bound and Total Vitamin D in the Blood: Full Study.
What is the central physiological distinction?
Total 25(OH)D includes DBP-bound, albumin-bound and free 25(OH)D. Under ordinary conditions DBP carries most of the circulating metabolite because its binding affinity is much higher than albumin’s. Albumin contributes weaker binding, while the free pool is extremely small.
Classic direct binding work estimated about 88% of 25(OH)D as DBP-bound and about 0.03% as free in normal serum, with most of the remainder associated with albumin. Those percentages vary with physiology and method, so they are best understood as an illustration of the normal hierarchy rather than universal constants.
Why does the carrier matter?
DBP helps determine the size of the total circulating reservoir. In liver disease, where DBP and albumin can be reduced, total 25(OH)D may fall while absolute free 25(OH)D is relatively preserved. Vitamin D Binding Protein Explained gives the wider carrier biology.
Common DBP phenotypes also influence total and free measures, although much less dramatically than complete loss of the protein. In a 472-person supplementation study, phenotype-related differences were more evident for total 25(OH)D and DBP than for directly measured free 25(OH)D.
What do rare GC mutations show?
Rare human loss of DBP provides a strong causal test. A 2019 patient with homozygous deletion of GC had a total 25(OH)D concentration of about 0.079 ng/mL, but directly measured free 25(OH)D was 1.8 pg/mL and calcium/PTH regulation was comparatively preserved. A later unrelated patient with a pathogenic GC variant likewise had extremely low total vitamin D metabolites without obligatory severe metabolic bone disease.
These cases show that total concentration is strongly carrier-dependent. They do not show that ordinary low total 25(OH)D is harmless. Complete DBP loss is an exceptional genetic state and cannot be treated as a model of routine deficiency.
Does free mean biologically active?
Not in a universal sense. Free 25(OH)D is unbound and therefore physically distinct, but circulating free concentration is not the same thing as tissue action. The selected studies do not map uptake and response across every tissue, so they cannot establish that DBP-bound material is biologically irrelevant everywhere. Intracellular activation and receptor signalling also occur downstream of the blood measurement.
Likewise, weaker albumin binding does not prove that the entire albumin-bound pool is uniformly available to every tissue. Vitamin D Transport Proteins explains why transport and tissue delivery cannot be reduced to one percentage.
How was this evidence generated?
The evidence comes from several different human designs rather than one repeated type of study. The foundational work directly measured the free fraction in serum and experimentally removed DBP to identify the weaker residual albumin binding. The liver-disease work then tested the same binding logic in people whose DBP and albumin concentrations were reduced.
Sollid and colleagues added common DBP phenotype information inside a randomised supplementation cohort. The two GC loss-of-function reports provided a different kind of evidence again: rare genetic natural experiments in which functional circulating DBP was absent. These designs answer different questions, which is why the strongest interpretation comes from their convergence rather than from treating any one study as decisive for every clinical situation.
What does this evidence not tell us?
It does not establish a universal tissue-access rule for free, albumin-bound or DBP-bound 25(OH)D. It does not define a universal free 25(OH)D target. It also does not show that a person with ordinary low total 25(OH)D and normal carrier biology resembles someone with complete genetic absence of DBP.
The key distinction is therefore physiological rather than prescriptive: carrier proteins shape what a total concentration represents. How that should affect interpretation depends on the person’s binding environment, the measurement method and the question being asked.
What should the reader take from this?
The best-supported model is conditional rather than competitive. Total 25(OH)D is a useful measure of the whole circulating pool. Free 25(OH)D identifies the unbound component. Albumin-bound 25(OH)D sits between the dominant DBP-bound reservoir and the free pool in binding strength. Changes in carrier biology can alter the relationship among them.
That physiological distinction becomes especially important when interpreting laboratory measurements. Continue to Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D for the distinction between the two major metabolites used in testing, or to Free Versus Total Vitamin D Measurement and Interpretation: Full Study for the direct free-versus-total question.
Primary studies
Bikle DD et al., 1986. Assessment of the Free Fraction of 25-Hydroxyvitamin D in Serum and Its Regulation by Albumin and the Vitamin D-Binding Protein.
Bikle DD et al., 1986. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.
Sollid ST et al., 2016. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
Henderson CM et al., 2019. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
Banerjee RR et al., 2021. Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein.
Related reading
Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites
The free 1,25(OH)2D DR was attenuated compared to that of total 1,25(OH)2D.
Original paper ↗Read more →Polymorphisms of the Vitamin D Binding Protein (VDBP) and Free Vitamin D in Patients with Cystic Fibrosis
Objectives/Background: Vitamin D-binding protein (VDBP) and free vitamin D are new markers that are being studied as a possible markers of vitamin D status.
Original paper ↗Read more →Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Original paper ↗Read more →Increased Plasma Concentrations of Vitamin D Metabolites and Vitamin D Binding Protein in Women Using Hormonal Contraceptives: A Cross-Sectional Study
Aim: In a cross-sectional study, plasma concentrations of vitamin D metabolites, VDBP, and the calculated free vitamin D index in users and non-users of HC were compared and markers of calcium and bone metabolism investigated.
Original paper ↗Read more →Potential roles of vitamin D binding protein in attenuating liver injury in sepsis
The current study examined the relationship between serum VDBP level and liver injury in sepsis patients, as well as in a mouse model for sepsis and in cultured liver epithelial cell line exposed to lipopolysaccharide (LPS).
Original paper ↗Read more →The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases
Vitamin D (calciferol) is a fat-soluble vitamin that has a significant role in phospho-calcium metabolism, maintaining normal calcium levels and bone health development.
Original paper ↗Read more →Vitamin D binding protein is lower in infertile patients compared to fertile controls: a case control study
This case control trial seeks to characterize vitamin D metabolism in infertile patients undergoing natural cycle IVF as compared to normally cycling premenopausal women with proven fertility matched for age and body mass index (BMI).
Original paper ↗Read more →The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes
Vitamin D is important for bone health, but may also have extra-skeletal effects.
Original paper ↗Read more →25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy
To evaluate vitamin D binding protein and free 25-hydroxyvitamin D [25(OH)D] levels in healthy controls compared to primary hyperparathyroidism (PHPT) patients, and to examine PHPT before and after surgery.
Original paper ↗Read more →Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation
We aimed to investigate the changes of total 25(OH)D, 25(OH)D3 and 25(OH)D2 in a Thai cohort, according to type of vitamin D supplement (vitamin D3 or D2) and DBP genotype, after receiving vitamin D3 or D2 for 3 months.
Original paper ↗Read more →Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein
Serum 25-hydroxyvitamin D [25(OH)D] is often deficient (.
Original paper ↗Read more →Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study
All participants were genotyped for polymorphisms rs2282679, rs4588, and rs7041.
Original paper ↗Read more →Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry
Our aim was to assess the combined effect of maternal and neonatal VDBP polymorphism heterogeneity in conjunction with different maternal and neonatal 25(OH)D cutoffs on the neonatal anthropometric profile at birth.
Original paper ↗Read more →The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population
Compared with VDI, VDS, or both, VDD showed higher plasma concentrations of fasting blood glucose, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides in males (P 0.05).
Original paper ↗Read more →Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland
We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7−19 yr.
Original paper ↗Read more →Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions
The aim of this review is to assess DBP concentration in different physiological and pathophysiological conditions.
Original paper ↗Read more →Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis
Blacks have different dominant polymorphisms in the vitamin D-binding protein (DBP) gene that result in higher bioavailable vitamin D than whites.
Original paper ↗Read more →Vitamin D Binding Protein Explained
A physiology-first explanation of vitamin D binding protein, detailing how it buffers circulation, regulates delivery, and shapes cellular and system-level vitamin D availability.
Read more →Free Versus Total Vitamin D Measurement and Interpretation: Full Study
Review human evidence comparing free and total vitamin D measurements, altered binding states, assay methods and implications for interpretation.
Read more →Associations of free, bioavailable and total 25-hydroxyvitamin D with neonatal birth anthropometry and calcium homoeostasis in mother-child pairs in a sunny Mediterranean region
Our objective was to examine the interrelated biodynamics of maternal and neonatal total, free and bioavailable 25(OH)D in maternal: neonatal dyads at birth and their associations with homeostasis and neonatal birth anthropometry.
Original paper ↗Read more →Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk
Correlations with Child: Pugh score, Barcelona Clinic Liver Cancer (BCLC) stage, and disease aetiology were evaluated.
Original paper ↗Read more →Original sources
Assessment of the Free Fraction of 25-Hydroxyvitamin D in Serum and Its Regulation by Albumin and the Vitamin D-Binding Protein
Bikle DD et al., 1986.
Publication details
Bikle DD et al., 1986. Assessment of the Free Fraction of 25-Hydroxyvitamin D in Serum and Its Regulation by Albumin and the Vitamin D-Binding Protein.
Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels
Bikle DD et al., 1986.
Publication details
Bikle DD et al., 1986. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.
Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
Sollid ST et al., 2016.
Publication details
Sollid ST et al., 2016. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene
Henderson CM et al., 2019.
Publication details
Henderson CM et al., 2019. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein
Banerjee RR et al., 2021.
Publication details
Banerjee RR et al., 2021. Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein.